THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA

Umberto Ricardi, Andrea Riccardo Filippi, Cristina Piva, Pierfrancesco Franco
  • Umberto Ricardi
    Radiation Oncology Department of Oncology University of Torino, Italy
  • Cristina Piva
    Radiation Oncology Department of Oncology University of Torino, Italy
  • Pierfrancesco Franco
    Radiation Oncology U. Parini Hospital Aosta, Italy

Abstract

Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin’s Lymphoma (HL). Nevertheless, late toxicity still remains an issue. A modern approach in HL radiotherapy includes lower doses and smaller fields, together with the implementation of sophisticated and dedicated delivery techniques. Aim of the present review is to discuss the current role of radiotherapy and its potential future developments, with a focus on major clinical trials, technological advances and their repercussion in the clinical management of HL patients.

Keywords

Hodgkin's Lymphoma; Radiotherapy;

Full Text:

PDF
HTML
Submitted: 2014-07-21 14:06:44
Published: 2014-05-30 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
785

Views:
PDF
347
HTML
5309

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185